Trial Profile
Effect of canagliflozin on serum uric acid and carotid femoral pulse wave velocity in type 2 diabetic patients with hypertension and normal renal function
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Jul 2018
Price :
$35
*
At a glance
- Drugs Canagliflozin (Primary) ; Amlodipine; Metformin
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics; Therapeutic Use
- 23 Jul 2018 New trial record
- 26 Jun 2018 Results presented at the 78th Annual Scientific Sessions of the American Diabetes Association